NCT07112053 2026-04-06
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
Phase 2 Recruiting
Clinical Trials
12 trialsNCT07407920 2026-02-12
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04915508 2025-06-22
EXCALIBUR
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT02188368 2023-11-03
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Oncotherapeutics
Phase 2 Terminated
NCT04810156 2022-12-14
I-HEP
Herlev Hospital
Phase 2 Unknown
NCT01874860 2022-12-01
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
University of Louisville
Phase 2 Completed
NCT03104270 2022-03-31
Combination Study for High Risk Multiple Myeloma Patients
Oncotherapeutics
Phase 2 Terminated
NCT04553510 2020-09-17
Treatment of Bevacizumab Followed by Steroid in RN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT03960151 2019-05-22
Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy
Hoosier Cancer Research Network
Phase 2 Withdrawn
NCT00040937 2016-12-08
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
SWOG Cancer Research Network
Phase 2 Completed
NCT00459641 2012-07-17
Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts
Kuros Biosurgery AG
Phase 2 Withdrawn
NCT00946374 2009-07-27
HD-MCL2003
Heidelberg University
Phase 2 Unknown